ETF profile
CapForce IBD 50 ETF logo

CapForce IBD 50 ETF (FFTY)

ETF overview

The CapForce IBD 50 ETF is designed to mirror the performance outcomes of the IBD 50 Index. Developed by Investor's Business Daily as its signature investment vehicle, the IBD 50 provides access to U.S. large and mid-sized companies that display robust earnings growth alongside strong stock price appreciation. This fund implements a consistent, systematic methodology to pinpoint stocks that align with its established leadership standards.

CountryUnited States of America
ExchangeAMEX
Trades inUSD
Current price
33.34 USD+1.43%
Close 21 Oct 2026
Interval
Benchmarks

Fund facts

Expense ratio
0.80%
Fund assets
63.33M USD (all share classes)
Issuer
Capital Force
Inception date
Apr 9, 2015
Number of holdings
52

Breakdown

Holdings (52)

NameTickerWeight
Halozyme Therapeutics IncHALO3.75%
Kiniksa Pharmaceuticals International PlcKNSA3.58%
Natera IncNTRA3.58%
Rubrik IncRBRK3.55%
Zeta Global Holdings CorpZETA3.54%
Paysign IncPAYS3.51%
Dorian LPG LtdLPG3.49%
Hinge Health IncHNGE3.40%
Okeanis Eco Tankers CorpECO3.37%
BBB Foods IncTBBB3.15%
and 39 more

Historical returns do not guarantee future returns. This is not investment advice.

CapForce IBD 50 ETF (FFTY)

FFTY · AMEX
33.34 USD+1.43%
Sign up to track this ETF
Benchmarks
Fund facts
Expense ratio
0.80%
Fund assets
63.33M USD (all share classes)
Issuer
Capital Force
Inception date
Apr 9, 2015
Number of holdings
52
Breakdown
Holdings (52)
NameTickerWeight
Halozyme Therapeutics IncHALO3.75%
Kiniksa Pharmaceuticals International PlcKNSA3.58%
Natera IncNTRA3.58%
Rubrik IncRBRK3.55%
Zeta Global Holdings CorpZETA3.54%
Paysign IncPAYS3.51%
Dorian LPG LtdLPG3.49%
Hinge Health IncHNGE3.40%
Okeanis Eco Tankers CorpECO3.37%
BBB Foods IncTBBB3.15%
and 39 more
ETF overview

The CapForce IBD 50 ETF is designed to mirror the performance outcomes of the IBD 50 Index. Developed by Investor's Business Daily as its signature investment vehicle, the IBD 50 provides access to U.S. large and mid-sized companies that display robust earnings growth alongside strong stock price appreciation. This fund implements a consistent, systematic methodology to pinpoint stocks that align with its established leadership standards.

CountryUnited States of America
Trades inUSD

Historical returns do not guarantee future returns. This is not investment advice.

Unlock all ETF data

Sign up for Free

Unlock all ETF data

Sign up for Free